Safety of Ciclesonide Nasal Spray Administered With Inhaled Fluticasone Dipropionate/Salmeterol in Adults With Perennial Allergic Rhinitis (BY9010/M1-409)

Main Inclusion Criteria: * General good health, other than perennial allergic rhinitis * History and diagnosis of perennial allergic rhinitis by skin prick * Normal body weight as defined by the study protocol Main Exclusion Criteria: * Pregnancy, nursing, or plans to become pregnant or donate gametes (ova or sperm) for in vitro fertilization during the study period or for 30 days following the study period * Participation in any investigational drug trial within the 30 days preceding the Screening Visit * A known hypersensitivity to any corticosteroid or any of the excipients in the formulations * Use of any prohibited concomitant medications as defined by the study protocol * Previous participation in an intranasal ciclesonide study * Non-vaccinated exposure to or active infection with, chickenpox or measles within the 21 days preceding the Screening Visit